✦ LIBER ✦

Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity

✍ Scribed by Lee A. Dawson; Zoë A. Hughes; Kathryn R. Starr; James D. Storey; Letizia Bettelini; Fabrizio Bacchi; Roberto Arban; Alessandro Poffe; Sergio Melotto; James J. Hagan; Gary W. Price

Book ID: 116784532
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 423 KB
Volume: 50
Category: Article
ISSN: 0028-3908
DOI: 10.1016/j.neuropharm.2006.01.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SB-616234-A (1-[6-(cis-3,5-dimethylpiper

SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′methyl-4′-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): A novel, potent and selective 5-HT1B receptor antagonist

✍ Claire Scott; Christopher J. Langmead; Kirsten L. Clarke; Paul Wyman; Paul W. Sm 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Synthesis and evaluation of the biologic

Synthesis and evaluation of the biological activities of some 3-{[5-(6-methyl-4-aryl-2-oxo-1,2,3,4-tetrahydropyrimidin-5-yl)-1,3,4-oxadiazol-2-yl]-imino}-1,3-dihydro-2H-indol-2-one derivatives

✍ George, Sonia; Parameswaran, Manoj Kumar; Chakraborty, Acharjee Raja; Ravi, Then 📂 Article 📅 2008 🏛 Versita 🌐 English ⚖ 135 KB

In vitro and in vivo pharmacological cha

In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V1A receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245)

✍ Rachel Russell; Rachel Doyle; Jamie Turner; Neil Attkins; Simeon Ramsey; Laura W 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 786 KB

ChemInform Abstract: Discovery and Precl

ChemInform Abstract: Discovery and Preclinical Studies of 5-Isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo [2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo Active Potent VEGFR-2 Inhibitor.

✍ Rejean Ruel; et al. et al. 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 20 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Discovery of N-[2-[5-[Amino(imino)methyl

Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro- 6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa1

✍ Phillips, Gary B.; Buckman, Brad O.; Davey, David D.; Eagen, Keith A.; Guilford, 📂 Article 📅 1998 🏛 American Chemical Society 🌐 English ⚖ 178 KB

The synthesis of three isotopomers of 2-

The synthesis of three isotopomers of 2-methyl-2-(4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-[1,2,4]triazol-3-yl]propyl]phenoxy)propionic acid, a potent and selective peroxisome proliferator-activated receptor alpha agonist

✍ Fengjiun Kuo; Dean K. Clodfelter; Nagy A. Farid; William J. Wheeler; Lennon H. M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 184 KB

## Abstract Although fenofibrate (**1a**) is commercially available and clinically effective in lowering serum triglycerides, its activity and sub‐type selectivity at the PPARα receptors are only moderate; therefore, there exists a need for more potent and sub‐type selective PPARα agonists. To that